Search results for "Abciximab"

showing 2 items of 12 documents

Acute and spontaneous coronary thrombosis in non-culprit artery during percutaneous coronary intervention in myocardial infarction with ST-segment el…

2015

lcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyAcute coronary syndromeTicagrelorCardiac & Cardiovascular Systemsmedicine.medical_treatmentAbciximabArticleSTEMICoronary thrombosisInternal medicinemedicineAbciximabST segmentMyocardial infarctionbusiness.industryPercutaneous coronary interventionPCImedicine.diseaselcsh:RC666-701Conventional PCICardiologyAcute coronary syndromeCardiology and Cardiovascular MedicinebusinessTicagrelorAcute and spontaneous occlusion of LADmedicine.drugIJC Heart & Vasculature
researchProduct

Antithrombotic therapy in acute coronary syndromes

2000

Current therapy of acute coronary syndromes (i.e., unstable angina and non-Q-wave myocardial infarction, Q-wave myocardial infarction) consists of thrombolytic, anti-platelet, and anti-coagulant therapy. In most cases of acute coronary syndromes, the pathogenesis is a mural thrombus formation on a ruptured or eroded atherosclerotic plaque. Both platelets and thrombin play an essential role in the pathophysiology of acute coronary syndromes. Aspirin and heparin are essential treatments for patients with acute coronary syndromes. Novel thrombin and platelet inhibitors have been developed and demonstrated useful effects for improving both acute and long-term clinical outcomes in acute coronary…

medicine.medical_specialtybusiness.industryUnstable anginaReteplaseTirofibanHeparinClopidogrelmedicine.diseaseInternal medicinemedicineAbciximabEptifibatideCardiologyMyocardial infarctionbusinessmedicine.drug
researchProduct